SEC Form D private-offering filing

ImmunoVec, Inc.

A new SEC Form D private-offering notice from Los Angeles, CA, a $14,999,944 filer-stated offering target in Biotech. The source filing is one click away.

ImmunoVec, Inc. site↗ Verified via SEC Form D

Los Angeles biotech developing an in vivo cell engineering platform, using DNA loaded polymeric nanoparticles to reprogram immune cells, to treat autoimmune diseases; backed by an ARPA H award.

Filed 2026-07-14Filed to raise $14,999,944First money in 2026-06-29Raised so far $12,705,822HQ (as filed) Los Angeles, CASector Biotech ✓Stage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified immunovec.com↗Named in the filing 4 executives & directors
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.